Tumor mutational burden in non-small cell lung cancer—the pathologist’s point of view

Por Penault-Llorca, Frédérique, Radosevic-Robin, Nina
Publicado no Transl Lung Cancer Res (2018)

Quantification of HER family receptors in breast cancer

Por Nuciforo, Paolo, Radosevic-Robin, Nina, Ng, Tony, Scaltriti, Maurizio
Publicado no Breast Cancer Res (2015)

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ

Por Beguinot, Marie, Dauplat, Marie-Melanie, Kwiatkowski, Fabrice, Lebouedec, Guillaume, Tixier, Lucie, Pomel, Christophe, Penault-Llorca, Frederique, Radosevic-Robin, Nina
Publicado no BMC Cancer (2018)

Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer

Por Bingula, Rea, Filaire, Marc, Radosevic-Robin, Nina, Bey, Mathieu, Berthon, Jean-Yves, Bernalier-Donadille, Annick, Vasson, Marie-Paule, Filaire, Edith
Publicado no J Oncol (2017)

BRCA1 Induces Major Energetic Metabolism Reprogramming in Breast Cancer Cells

Por Privat, Maud, Radosevic-Robin, Nina, Aubel, Corinne, Cayre, Anne, Penault-Llorca, Frédérique, Marceau, Geoffroy, Sapin, Vincent, Bignon, Yves-Jean, Morvan, Daniel
Publicado em 2014

Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: Study protocol for case-control observational trial

Por Bingula, Rea, Filaire, Marc, Radosevic-Robin, Nina, Berthon, Jean-Yves, Bernalier-Donadille, Annick, Vasson, Marie-Paule, Thivat, Emilie, Kwiatkowski, Fabrice, Filaire, Edith
Publicado no Medicine (Baltimore) (2018)

Homoharringtonine, an approved anti-leukemia drug, suppresses triple negative breast cancer growth through a rapid reduction of anti-apoptotic protein abundance

Por Yakhni, Mohamad, Briat, Arnaud, El Guerrab, Abderrahim, Furtado, Ludivine, Kwiatkowski, Fabrice, Miot-Noirault, Elisabeth, Cachin, Florent, Penault-Llorca, Frederique, Radosevic-Robin, Nina
Publicado no Am J Cancer Res (2019)

[(18)F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer

Por Jouberton, Elodie, Schmitt, Sébastien, Chautard, Emmanuel, Maisonial-Besset, Aurélie, Roy, Marie, Radosevic-Robin, Nina, Chezal, Jean-Michel, Miot-Noirault, Elisabeth, Bouvet, Yann, Cachin, Florent
Publicado no EJNMMI Res (2020)

DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition

Por Ollier, Marie, Radosevic-Robin, Nina, Kwiatkowski, Fabrice, Ponelle, Flora, Viala, Sandrine, Privat, Maud, Uhrhammer, Nancy, Bernard-Gallon, Dominique, Penault-Llorca, Frédérique, Bignon, Yves-Jean, Bidet, Yannick
Publicado no Am J Cancer Res (2015)

Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model

Por Chaput, Laure, Grèze, Victoria, Halle, Pascale, Radosevic-Robin, Nina, Pereira, Bruno, Véronèse, Lauren, Lejeune, Hervé, Durand, Philippe, Martin, Guillaume, Sanfilippo, Sandra, Canis, Michel, Kanold, Justyna, Tchirkov, Andrei, Brugnon, Florence
Publicado no Cancers (Basel) (2019)

Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy

Por Leconet, Wilhem, Larbouret, Christel, Chardès, Thierry, Thomas, Gaëlle, Neiveyans, Madeline, Busson, Muriel, Jarlier, Marta, Radosevic-Robin, Nina, Pugnière, Martine, Bernex, Florence, Penault-Llorca, Frédérique, Pasquet, Jean-Max, Pèlegrin, André, Robert, Bruno
Publicado no Oncogene (2014)

HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models

Por Thomas, GaëLle, ChardèS, Thierry, Gaborit, NadèGe, Mollevi, Caroline, Leconet, Wilhem, Robert, Bruno, Radosevic-Robin, Nina, Penault-Llorca, FréDéRique, Gongora, CéLine, Colombo, Pierre-Emmanuel, Lazrek, Yassamine, Bras-Goncalves, Rui, Savina, Ariel, Azria, David, Bazin, Hervé, PèLegrin, André, Larbouret, Christel
Publicado em 2014

SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cance...

Por Llombart-Cussac, Antonio, Bermejo, Begoña, Villanueva, Cristian, Delaloge, Suzette, Morales, Serafín, Balmaña, Judith, Amillano, Kepa, Bonnefoi, Hervé, Casas, Ana, Manso, Luis, Roché, Henri, Gonzalez-Santiago, Santiago, Gavilá, Joaquín, Sánchez-Rovira, Pedro, Di Cosimo, Serena, Harbeck, Nadia, Charpentier, Eric, Garcia-Ribas, Ignacio, Radosevic-Robin, Nina, Aura, Claudia, Baselga, Jose
Publicado no Breast Cancer Res Treat (2015)

Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer

Por Tao, Jessica J., Castel, Pau, Radosevic-Robin, Nina, Elkabets, Moshe, Auricchio, Neil, Aceto, Nicola, Weitsman, Gregory, Barber, Paul, Vojnovic, Borivoj, Ellis, Haley, Morse, Natasha, Viola-Villegas, Nerissa Therese, Bosch, Ana, Juric, Dejan, Hazra, Saswati, Singh, Sharat, Kim, Phillip, Bergamaschi, Anna, Maheswaran, Shyamala, Ng, Tony, Penault-Llorca, Frédérique, Lewis, Jason S., Carey, Lisa A., Perou, Charles M., Baselga, José, Scaltriti, Maurizio
Publicado no Sci Signal (2014)

Stratification and therapeutic potential of PML in metastatic breast cancer

Por Martín-Martín, Natalia, Piva, Marco, Urosevic, Jelena, Aldaz, Paula, Sutherland, James D., Fernández-Ruiz, Sonia, Arreal, Leire, Torrano, Verónica, Cortazar, Ana R., Planet, Evarist, Guiu, Marc, Radosevic-Robin, Nina, Garcia, Stephane, Macías, Iratxe, Salvador, Fernando, Domenici, Giacomo, Rueda, Oscar M., Zabala-Letona, Amaia, Arruabarrena-Aristorena, Amaia, Zúñiga-García, Patricia, Caro-Maldonado, Alfredo, Valcárcel-Jiménez, Lorea, Sánchez-Mosquera, Pilar, Varela-Rey, Marta, Martínez-Chantar, Maria Luz, Anguita, Juan, Ibrahim, Yasir H., Scaltriti, Maurizio, Lawrie, Charles H., Aransay, Ana M., Iovanna, Juan L., Baselga, Jose, Caldas, Carlos, Barrio, Rosa, Serra, Violeta, dM Vivanco, Maria, Matheu, Ander, Gomis, Roger R., Carracedo, Arkaitz
Publicado no Nat Commun (2016)